Tag Directory / HEALTHCAREFINANCE     showing 21–31 of 31


AI blood test finds silent liver disease years before symptoms / Science Daily Cancer

sciencedaily - Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wid…

#healthcare #publichealth #biotech #digitalhealth #medicaldevices #healthcarefinance

Karamvir Yadav on Transforming Breast Cancer Diagnosis with Fragmentomic Blood Tests

3 days / oncodaily

Uncovering a key signaling pathway linking liver cancer and fibrosis

3 days / medicalxpress

Ali Choukair Presents a 360° Approach to Metabolic Liver Disease – Emirates Digestive Diseases Week

9 days / oncodaily

ImmunoXXL Phase 2 Study: Liver Transplantation After Atezolizumab–Bevacizumab Downstaging in Advanced HCC

9 days / oncodaily

AI blood test finds silent liver disease years before symptoms

10 days / sciencedaily

AI-based liquid biopsy may detect liver fibrosis, cirrhosis and chronic disease signals

12 days / medicalxpress

Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases

12 days / science / Akshaya V. Annapragada, Zachariah H. Foda, Hope Orjuela, Carter Norton, Shashikant Koul, Noushin Nik

Friday, March 6, 2026, 1:22 am / permalink 20251 / 7 stories in 10 days


Amazon launches Amazon Connect Health / Beckers

Naomi Diaz / beckershospitalreview - Amazon Web Services has launched Amazon Connect Health, an artificial intelligence tool designed to automate administrative tasks for health systems and improve patient access to care. Here are six things to know about Amazon Connect Health: Amazon Connec…

#healthcare #digitalhealth #hospitaloperations #healthcarefinance

New framework ensuring ethical and fair use of AI in health care

3 days / medicalxpress

Nurses navigate AI-generated health information at bedside

3 days / beckershospitalreview / Giles Bruce

Stanford Health Care leader to advise agentic AI startup

3 days / beckershospitalreview / Giles Bruce

Judge orders UnitedHealth to hand over documents in AI coverage denial case

3 days / beckershospitalreview / Jakob Emerson

CMS’ Oz envisions agentic AI in the hands of every Medicare beneficiary

3 days / beckershospitalreview / Elizabeth Casolo

Amazon launches health AI agent on its website, expands free virtual care to 200M Prime members

3 days / fiercehealthcare

Microsoft unveils AI health tool that can read your medical records

3 days / medicalxpress

The buzz at HIMSS 2026: 6 notes

3 days / beckershospitalreview / Giles Bruce

Mount Sinai study: Multi-agent AI handles heavy clinical workloads better

3 days / beckershospitalreview / Naomi Diaz

Healthcare’s ‘AI tourism’ era is over: Columbia Business School

3 days / beckershospitalreview / Giles Bruce

UC Davis Health pilots AI scribe training for emergency medicine residents

3 days / beckershospitalreview / Naomi Diaz

CMS wants seniors to use AI for care navigation

3 days / healthcaredive / Emily Olsen

Screening with AI could cut unnecessary glaucoma referrals by half

3 days / medicalxpress

Computing power is no longer the AI bottleneck — it's energy production

3 days / livescience

Microsoft Enters Healthcare Chatbot Race with Copilot Health

4 days / medcitynews / Katie Adams

Richard Dirven Calls for Responsible Integration of AI in Precision Oncology Care

9 days / oncodaily

CVS, Humana & More Are Turning to Google’s AI Models

10 days / medcitynews / Katie Adams

Highmark Health generates $28M in value with Google AI

10 days / beckershospitalreview / Giles Bruce

Privacy Expectations in Consumer AI Tools: How Patient Use of ChatGPT Health and Claude Differs From HIPAA-Regulated Care

10 days / medcitynews / Nirmal Vemanna

How to use AI tools to support our wellbeing in safe and simple ways

10 days / bbc

Future of Health Tech: From Structured Data to Scalable AI [Video]

10 days / medcitynews / wlim

Salesforce partners with HealthEx, Verily and Viz.ai to build out healthcare AI agents

11 days / fiercehealthcare

Optum expands Microsoft collaboration to add AI to claims platform

11 days / beckershospitalreview / Naomi Diaz

4 health system leaders join initiative to improve patient safety with AI

11 days / beckershospitalreview / Giles Bruce

AI Startups Are Tying Fees to Completed Tasks. Will Hospitals Buy In?

11 days / medcitynews / Katie Adams

Microsoft unveils new Dragon Copilot AI capabilities for clinicians

11 days / beckershospitalreview / Naomi Diaz

Optum teams with Microsoft to expand AI-powered claims platform

11 days / fiercehealthcare

Waystar expanding Google Cloud collaboration

11 days / beckershospitalreview / Andrew Cass

The algorithm will see you now? Patients say not without a doctor nearby

11 days / medicalxpress

Amazon launches Amazon Connect Health

11 days / beckershospitalreview / Naomi Diaz

Amazon launches suite of healthcare AI agents

11 days / healthcaredive / Emily Olsen

When Artificial Intelligence Starts Rewriting Reality

11 days / thehealthcareblog / matthew holt

AWS offers agentic AI solution to tackle scheduling, ambient note-taking and medical coding

11 days / fiercehealthcare

Thursday, March 5, 2026, 11:23 am / permalink 20205 / 33 stories in 11 days


Novo Nordisk inks $2.1B oral obesity drug deal / Beckers

Ella Jeffries / beckershospitalreview - Novo Nordisk has partnered with Vivtex Corp. to develop next-generation oral biologic medicines for obesity, diabetes and related conditions. Under the agreement, Vivtex will license its proprietary oral drug-delivery technologies to Novo Nordisk and is e…

#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #biotech #drugdevelopment #healthcarefinance

Gubra plots Roivant-like model as partnered obesity drugs take flight

3 days / endpoints / Kyle LaHucik

Pfizer gets obesity drug approval in China shortly after buying local rights

10 days / endpoints / Elizabeth Cairns

Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity

11 days / medicalxpress

Roche partner Zealand posts Phase 2 data for amylin obesity drug

11 days / endpoints / Kyle LaHucik

Novo Nordisk details Irish expansion; EuroAPI’s challenges continue

11 days / endpoints / Anna Brown

What to know about how GLP-1 medications might fight addiction

11 days / medicalxpress

Twenty percent of eligible youth prescribed GLP-1 receptor agonists

12 days / medicalxpress

GLP-1 medications get at the heart of addiction, study finds

12 days / medicalxpress

Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last

12 days / medicalxpress

Eli Lilly launches its direct-to-employer platform for obesity drugs

12 days / fiercehealthcare

Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds

12 days / nytimes / Roni Caryn Rabin

AHA urges HHS to block Novo Nordisk’s 340B data demand

12 days / beckershospitalreview / Paige Twenter

FDA sends Novo Nordisk 2nd warning over GLP-1 ads

12 days / beckershospitalreview / Erica Cerutti

How gut bacteria and diet can reprogram fat to burn more energy

12 days / medicalxpress

No more weekly injections? How lettuce cells could deliver GLP-1 pills

12 days / medicalxpress

GLP-1 weight-loss drugs comparably effective across age, race and starting weight

12 days / medicalxpress

FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters

13 days / fiercehealthcare

FDA warns 30 telehealth firms over compounded GLP-1 claims

13 days / beckershospitalreview / Ella Jeffries

Hims partner Strive Pharmacy will reintroduce GLP-1 pill pulled from market

13 days / endpoints / Shelby Livingston

Novo Nordisk inks $2.1B oral obesity drug deal

14 days / beckershospitalreview / Ella Jeffries

Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds

19 days / medcitynews / Frank Vinluan

Novo Nordisk teams with Langer-founded biotech for oral obesity drugs

19 days / endpoints / Kyle LaHucik

Tuesday, March 3, 2026, 1:22 am / permalink 20039 / 22 stories in 13 days


Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints

Lei Lei Wu / endpoints - Atrium Therapeutics launched Friday morning as Novartis closed the $12 billion deal to buy Avidity Biosciences and its RNA muscle therapies. The spinout will take on Avidity’s early-stage programs for genetic cardiomyopathies — heart muscle diseases ...

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #healthcarefinance

Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions

15 days / medcitynews / Frank Vinluan

Novartis closes Avidity deal as rare heart disease spinout launches

17 days / endpoints / Lei Lei Wu

Monday, March 2, 2026, 12:23 am / permalink 19968 / 2 stories in 14 days


After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay / MedCity

Katie Adams / medcitynews - About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified.The post After 4-Week Strike, Kais…

#healthcare #publichealth #hospitaloperations #healthcarefinance

The Kaiser Settlement Should End the Guesswork in Medicare Advantage Oversight

11 days / medcitynews / David Lareau

2,400 Kaiser mental health workers to hold 1-day strike

11 days / beckershospitalreview / Kelly Gooch

Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer

14 days / beckershospitalreview / Vedant Bhosale

Four Proven Approaches to Stabilizing Clinical Operations

14 days / beckershospitalreview / Vedant Bhosale

Clinician Engagement: The Operating Lever Behind Margin and Throughput

14 days / beckershospitalreview / Vedant Bhosale

Work environment, moral resilience help nurses prevent moral injury

14 days / medicalxpress

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay

19 days / medcitynews / Katie Adams

31,000 Kaiser workers end strike; mental health clinicians back walkout: 6 notes

21 days / beckershospitalreview / Kelly Gooch

Saturday, February 28, 2026, 12:22 pm / permalink 19945 / 8 stories in 16 days


Merck Splits Oncology Business Unit as Keytruda Patent Expiry Nears / OncoDaily

oncodaily - On February 23, 2026, Merck announced a reorganization of its Human Health structure into two business units: an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. […]

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #healthcarefinance

Merck KGaA drops two cancer trials on assets from SpringWorks deal

11 days / endpoints / Reynald Castaneda

No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with Second-Line Treatment in Patients with HR-positive, HER2-negative ABC

13 days / esmo

Cancer Research UK partners with the Royal College of Surgeons of England to help people with rectal cancer avoid unnecessary surgery

13 days / cancerresearchuk / Krishna Sharma

A domain-adaptive deep contrastive network for magnetic resonance imaging-driven bladder cancer classification

14 days / nature

Multicenter ex vivo evaluation of an α-mannosidase–targeted fluorescent probe for intraoperative margin assessment in breast cancer

14 days / nature

Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123

14 days / nature

Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvima

16 days / endpoints / Nicole DeFeudis

Merck Splits Oncology Business Unit as Keytruda Patent Expiry Nears

18 days / oncodaily

Merck reorganizes; Blackstone to fund trials for J&J drug

21 days / endpoints / ENDPOINTS

Saturday, February 28, 2026, 3:22 am / permalink 19937 / 9 stories in 16 days


Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model / Fierce

fiercehealthcare - Teladoc Health reported better-than-expected fourth quarter financial results with both revenue and earnings exceeding analysts' expectations, driving a 15% jump in the company's stock Thursday.

#healthcare #governmentpolicy #digitalhealth #healthcarefinance

Why Telehealth Skills Belong at the Core of Clinical Education

15 days / beckershospitalreview / Nikhil Gaikwad

Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model

18 days / fiercehealthcare

Teladoc projects lower integrated care membership amid ACA subsidy lapse

18 days / healthcaredive / Emily Olsen

Saturday, February 28, 2026, 3:22 am / permalink 19936 / 3 stories in 16 days


CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health / Fierce

fiercehealthcare - Elevance Health Chief Financial Officer Mark Kaye will grow his list of duties to include oversight of Carelon, the company announced Thursday.

#healthcare #digitalhealth #behavioralhealth #healthcarefinance

CMS threatens Elevance with Medicare Advantage sanctions

13 days / healthcaredive / Rebecca Pifer Parduhn

CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans

14 days / fiercehealthcare

CMS to suspend enrollment into Elevance’s Medicare Advantage plans

14 days / beckershospitalreview / Elizabeth Casolo

How Leading Health Systems Are Mastering the Next Capacity Surge

14 days / beckershospitalreview / Vedant Bhosale

Elevance shuffles C-suite as top Carelon exec departs

17 days / healthcaredive / Rebecca Pifer Parduhn

CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health

18 days / fiercehealthcare

Saturday, February 28, 2026, 2:21 am / permalink 19934 / 6 stories in 16 days


Novartis to build $23B radioligand therapy site / Beckers

Ella Jeffries / beckershospitalreview - Novartis will construct a 46,000-square-foot radioligand therapy manufacturing site in Denton, Texas, as part of its $23 billion U.S. investment. The facility will be Novartis’ fifth radioligand therapy site in the U.S. and its first in Texas, according t…

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #healthcarefinance

Oklahoma pharmacy school to expand radiopharmaceutical access with new facility

11 days / beckershospitalreview / Ella Jeffries

Novartis to build $23B radioligand therapy site

18 days / beckershospitalreview / Ella Jeffries

Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer

18 days / endpoints / Anna Brown

Saturday, February 28, 2026, 12:23 am / permalink 19926 / 3 stories in 16 days


Generate Biomedicines’ $400M IPO Puts AI Drug Discovery Back in Focus / OncoDaily

oncodaily - Generate Biomedicines priced its U.S. initial public offering on February 26, 2026, selling 25 million shares at $16 each for gross proceeds of $400 million, with trading expected on the Nasdaq under […]

#healthcare #pharmaceuticals #biotech #drugdevelopment #digitalhealth #healthcarefinance

China obesity biotech QL Biopharm gets $72M, including support from OrbiMed

14 days / endpoints / Kyle LaHucik

Minding the gap – what does China’s biotech boom mean for the UK?

14 days / cancerresearchuk / Tim Bodicoat

Generate Biomedicines’ $400M IPO Puts AI Drug Discovery Back in Focus

16 days / oncodaily

Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug

17 days / medcitynews / Frank Vinluan

Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design

17 days / endpoints / Andrew Dunn

AbbVie budgets $380M for obesity and neuroscience API facilities in Chicago

21 days / endpoints / Anna Brown

Friday, February 27, 2026, 11:22 pm / permalink 19912 / 6 stories in 16 days


UHS posts 11.5% operating margin in 2025 as net income jumps 30% / Beckers

Andrew Cass / beckershospitalreview - King of Prussia, Pa.-based Universal Health Services recorded a net income of $1.5 billion in 2025, up from $1.1 billion in 2024, according to its Feb. 25 financial report. Eight things to know: 1. The for-profit system reported an operating income of $2 …

#healthcare #publichealth #governmentpolicy #behavioralhealth #hospitaloperations #healthcarefinance

UHS to roll out behavioral health revenue cycle AI tools in 2026

14 days / beckershospitalreview / Andrew Cass

CEOs, CFOs leading the 10 largest health systems — HCA, CommonSpirit and more

17 days / beckershospitalreview / Kristin Kuchno

Sarasota Memorial disputes OIG audit alleging $12.1M in Medicare overpayments

17 days / beckershospitalreview / Andrew Cass

Medicare Advantage enrollment declines for first time in 7 states: 9 notes

17 days / beckershospitalreview / Jakob Emerson

66 hospitals with the most ED visits in 2025

17 days / beckershospitalreview / Anna Falvey

IU Health consolidates regions, folds 2 hospitals into academic structure

17 days / beckershospitalreview / Alan Condon

UHS expects 25%–30% drop in ACA exchange volumes in 2026

17 days / beckershospitalreview / Andrew Cass

UHS eyes rising admissions targets this year despite headwinds

17 days / healthcaredive / Sydney Halleman

Universal Health Services forecasts more revenue, earnings gains for 2026

19 days / fiercehealthcare

UHS posts 11.5% operating margin in 2025 as net income jumps 30%

19 days / beckershospitalreview / Andrew Cass

Friday, February 27, 2026, 11:25 am / permalink 19887 / 10 stories in 17 days


Back to Top


HEALTHCAREFINANCE Heatmap

90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.



More Top Stories...

FDA refuses to review Moderna mRNA flu vaccine application

Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making. More...


FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval

AstraZeneca’s application to market its subcutaneous prefilled pen formulation of Saphnelo for treating lupus has hit a roadblock after the FDA issued a complete response letter. The decision delays the drug’s approval and raises questions about its future in the competitive immunotherapy market. More...


CMS proposes sweeping changes to ACA marketplace plan rules

CMS has proposed a major rule reshaping Affordable Care Act marketplace policies, including loosening limits on non-standard plan designs and promoting lower-premium options such as catastrophic coverage. The agency says the changes will reduce costs and boost flexibility, while critics warn they could increase confusion and weaken consumer protections—because shopping for insurance clearly wasn’t complicated enough. More...


Tenet forecasts major ACA exchange enrollment drop and financial hit

Tenet Healthcare is warning that the expiration of enhanced Affordable Care Act premium tax credits will drive a steep reduction in ACA exchange enrollment, projecting a significant revenue impact in 2026. Despite the headwind, the company says it expects earnings growth, leaning on acuity and operational performance—because nothing calms Wall Street like “we’ll make it up somewhere else.” More...


City of Hope promotes Nisha Morris to senior marketing chief

City of Hope named Nisha Morris as Senior Vice President and Chief Marketing and Communications Officer, adding marketing leadership to its executive team. The move signals a renewed focus on brand, outreach, and patient engagement as the cancer center sharpens its communication and growth strategies. More...


NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.